Cargando…
Blocking Short-Form Ron Eliminates Breast Cancer Metastases through Accumulation of Stem-Like CD4(+) T Cells That Subvert Immunosuppression
Immunotherapy has potential to prevent and treat metastatic breast cancer, but strategies to enhance immune-mediated killing of metastatic tumors are urgently needed. We report that a ligand-independent isoform of Ron kinase (SF-Ron) is a key target to enhance immune infiltration and eradicate metas...
Autores principales: | Lai, Shu-Chin Alicia, Gundlapalli, Harika, Ekiz, H. Atakan, Jiang, Amanda, Fernandez, Elvelyn, Welm, Alana L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8800951/ https://www.ncbi.nlm.nih.gov/pubmed/34330779 http://dx.doi.org/10.1158/2159-8290.CD-20-1172 |
Ejemplares similares
-
RON promotes the metastatic spread of breast carcinomas by subverting antitumor immune responses
por: Eyob, Henok, et al.
Publicado: (2013) -
Inhibition of RON kinase potentiates anti-CTLA-4 immunotherapy to shrink breast tumors and prevent metastatic outgrowth
por: Ekiz, Huseyin Atakan, et al.
Publicado: (2018) -
Short-form Ron is a novel determinant of ovarian cancer initiation and progression
por: Moxley, Katherine M., et al.
Publicado: (2016) -
mTORC1 is a key mediator of RON-dependent breast cancer metastasis with therapeutic potential
por: Faham, Najme, et al.
Publicado: (2018) -
The RON Receptor Tyrosine Kinase Promotes Metastasis by Triggering MBD4-Dependent DNA Methylation Reprogramming
por: Cunha, Stéphanie, et al.
Publicado: (2014)